On January 6, 2021 Akebia Therapeutics, Inc. (Nasdaq: AKBA), a biopharmaceutical company with the purpose to better the lives of people impacted by kidney disease, reported that John P. Butler, President and Chief Executive Officer, will participate in a fireside chat at the H.C. Wainwright Bioconnect 2021 Conference, which takes place virtually January 11 – 14, 2021 (Press release, Akebia, JAN 6, 2021, View Source/news-releases/news-release-details/akebia-therapeutics-present-hc-wainwright-bioconnect-2021" target="_blank" title="View Source/news-releases/news-release-details/akebia-therapeutics-present-hc-wainwright-bioconnect-2021" rel="nofollow">View Source [SID1234573563]).

Schedule your 30 min Free 1stOncology Demo!
Discover why more than 1,500 members use 1stOncology™ to excel in:

Early/Late Stage Pipeline Development - Target Scouting - Clinical Biomarkers - Indication Selection & Expansion - BD&L Contacts - Conference Reports - Combinatorial Drug Settings - Companion Diagnostics - Drug Repositioning - First-in-class Analysis - Competitive Analysis - Deals & Licensing

                  Schedule Your 30 min Free Demo!

The recorded presentation will be available on the Investors section of the Company’s website at View Source beginning Monday, January 11.